Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eagle Pharmaceuticals, Inc. (EGRX)  
$3.56 0.15 (4.04%) as of 4:30 Mon 6/10


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 13,030,000
Market Cap: 46.39(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $3.34 - $22.88
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  634
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eagle Pharmaceuticals is a pharmaceutical company focused on developing medicines to treat diseases of the central nervous system or metabolic critical care therapeutic areas as well as in oncology. Co.'s products include: Belrapzo® (bendamustine ready-to-dilute (RTD) 500ml solution), Bendeka® (infused bendamustine RTD) and Treakisym® for chronic lymphocytic leukemia and non-hodgkin's lymphoma; Ryanodex® (dantrolene sodium) for malignant hyperthermia; EP-4104 Ryanodex® (dantrolene sodium) for the treatment of organophosphate exposure; PEMFEXY™ (pemetrexed for injection) for lung cancer; and EA-114 (fulvestrant) for breast cancer.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 20,245 87,045
Total Sell Value $0 $0 $300,027 $1,741,115
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 2 7
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 199
  Page 6 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Schreiber Alain 10% Owner   –       –       •   2017-03-23 4 S $83.01 $58,107 I/I (700) 3,778,087     -
   Krill Steven L. EVP & Chief Scientific Officer   •       –      –    2017-03-22 4 S $80.09 $568,641 D/D (7,100) 0     -
   Krill Steven L. EVP & Chief Scientific Officer   •       –      –    2017-03-22 4 OE $4.42 $48,517 D/D 7,100 7,100     -
   Edlin Richard A. Director   –       •      –    2017-03-22 4 B $79.44 $476,640 D/D 6,000 29,400 2.39     -
   Schreiber Alain 10% Owner   –       –       •   2017-03-21 4 S $83.10 $41,550 I/I (500) 3,778,787     -
   Pernock David Pres. & Chief Comm. Officer   •       –      –    2017-03-21 4 B $83.98 $5,123 D/D 61 511 2.74     -
   Schreiber Alain 10% Owner   –       –       •   2017-03-20 4 S $82.10 $4,259,594 I/I (51,883) 3,779,287     -
   Edlin Richard A. Director   –       •      –    2017-03-17 3 IO $0.00 $0 D/D 0 23,400     -
   Schreiber Alain 10% Owner   –       –       •   2017-03-17 4 S $82.01 $3,198,144 I/I (38,997) 3,831,170     -
   Schreiber Alain 10% Owner   –       –       •   2017-03-16 4 S $82.08 $748,570 I/I (9,120) 3,870,167     -
   Pernock David Pres. & Chief Comm. Officer   •       –      –    2017-03-09 4 B $77.84 $35,028 D/D 450 450 2.74     -
   Schreiber Alain 10% Owner   –       –       •   2017-01-04 4 S $85.16 $5,545,108 I/I (65,114) 3,879,287     -
   Krill Steven L. EVP & Chief Scientific Officer   •       –      –    2016-12-23 4 S $78.61 $403,018 D/D (5,127) 0     -
   Krill Steven L. EVP & Chief Scientific Officer   •       –      –    2016-12-23 4 OE $46.09 $236,303 D/D 5,127 5,127     -
   Krill Steven L. EVP & Chief Scientific Officer   •       –      –    2016-12-22 4 S $76.78 $393,571 D/D (5,126) 0     -
   Krill Steven L. EVP & Chief Scientific Officer   •       –      –    2016-12-22 4 OE $46.09 $236,257 D/D 5,126 5,126     -
   Krill Steven L. EVP & Chief Scientific Officer   •       –      –    2016-12-21 4 S $77.17 $791,195 D/D (10,252) 0     -
   Krill Steven L. EVP & Chief Scientific Officer   •       –      –    2016-12-21 4 OE $12.63 $382,742 D/D 10,252 7,569     -
   Krill Steven L. EVP & Chief Scientific Officer   •       –      –    2016-12-20 4 S $76.69 $766,876 D/D (10,000) 0     -
   Krill Steven L. EVP & Chief Scientific Officer   •       –      –    2016-12-20 4 OE $12.63 $126,300 D/D 10,000 10,000     -
   Krill Steven L. EVP & Chief Scientific Officer   •       –      –    2016-12-19 4 S $75.61 $756,066 D/D (10,000) 0     -
   Krill Steven L. EVP & Chief Scientific Officer   •       –      –    2016-12-19 4 OE $12.63 $126,407 D/D 10,000 7,317     -
   Krill Steven L. EVP & Chief Scientific Officer   •       –      –    2016-12-15 4 S $74.79 $747,896 D/D (10,000) 0     -
   Krill Steven L. EVP & Chief Scientific Officer   •       –      –    2016-12-15 4 OE $4.42 $95,928 D/D 10,000 6,270     -
   Krill Steven L. EVP & Chief Scientific Officer   •       –      –    2016-12-13 4 S $73.62 $736,163 D/D (10,000) 0     -
  199 Records found
  1  2  3  4  5  6  7  8   
  Page 6 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us